Literature DB >> 23881382

Aberrant sphingolipid metabolism in the human fallopian tube with ectopic pregnancy.

Xiaolin Gao1, Nannan Ning, Beihua Kong, Yongping Xu, Hui Xu, Chengjun Zhou, Su Li, Yi Shao, Jianqing Qiu, Jingxin Li.   

Abstract

Sphingosine 1-phosphate (S1P), a product of sphingomyelin metabolism, is generated via phosphorylation of sphingosine by sphingosine kinases (SphK). It acts via a family of G protein-coupled receptors or as an intracellular second messenger for agonists acting through the S1P receptors (S1P1-5). In our study, the expression of SphK1 and S1P1 was identified by immunohistochemistry and immunoblot. The concentration of S1P was measured using ELISA. The spontaneous contraction of isolated fallopian tube strips was determined by tension recording. Our results showed that SphK1 and S1P1 were localized in the fallopian tube epithelial cells. In addition, smooth muscle cells also contained S1P1. Compared with the intrauterine pregnancy group, SPHK1 and S1P1 were overexpressed in ectopic pregnancy. However, the S1P concentration within the human oviduct from ectopic pregnancy subjects was largely reduced than that from normal pregnancy subject. The results from tension recording indicated that exogenous and intracellularly generated S1P can regulate the spontaneous contraction of oviduct isolated from rats and human. In conclusion, the sphingolipid metabolism signal pathway functionally existed in the human fallopian tube. Aberrant sphingolipid metabolism in the human fallopian tube may be involved in ectopic pregnancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881382     DOI: 10.1007/s11745-013-3818-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  32 in total

1.  Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis.

Authors:  D English; Z Welch; A T Kovala; K Harvey; O V Volpert; D N Brindley; J G Garcia
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

2.  Sphingosine 1-phosphate and control of vascular tone.

Authors:  Ana Paula V Dantas; Junsuke Igarashi; Thomas Michel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06       Impact factor: 4.733

3.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice.

Authors:  Kiyomi Mizugishi; Cuiling Li; Ana Olivera; Jacek Bielawski; Alicja Bielawska; Chu-Xia Deng; Richard L Proia
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

5.  Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA.

Authors:  Carlos Ocaña-Morgner; Peter Reichardt; Michaël Chopin; Sarah Braungart; Christine Wahren; Matthias Gunzer; Rolf Jessberger
Journal:  J Immunol       Date:  2011-03-18       Impact factor: 5.422

Review 6.  Sphingosine 1-phosphate signalling in mammalian cells.

Authors:  S Pyne; N J Pyne
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

Review 7.  Pleiotropic actions of sphingosine-1-phosphate.

Authors:  Kenneth Watterson; Heidi Sankala; Sheldon Milstien; Sarah Spiegel
Journal:  Prog Lipid Res       Date:  2003-07       Impact factor: 16.195

8.  Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.

Authors:  Y Sadahira; F Ruan; S Hakomori; Y Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 9.  Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.

Authors:  Wolfgang Siess
Journal:  Biochim Biophys Acta       Date:  2002-05-23

Review 10.  Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?

Authors:  Fumikazu Okajima
Journal:  Biochim Biophys Acta       Date:  2002-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.